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background: Although patients with type 2 diabetes (T2DM) are at high risk of cardiovascular (CV) events, the factors associated with risk are 
unclear. We examined the predictors of CV mortality and morbidity in a high risk population with T2DM (history of chronic kidney or CV disease or 
both) in the Aliskiren Trial in Type 2 Diabetes Using Cardiorenal Endpoints (ALTITUDE).
methods: In 8415 patients with complete data, we identified the predictors of the composite of CV death, MI, stroke, heart failure or resuscitated 
cardiac arrest (N=1129), adjusting for randomized therapy in a Cox model. The incremental information from N-terminal proBNP (NT-proBNP) and 
high-sensitivity troponin T (hsTnT) (available in 5598) was assessed by C statistics and net reclassification improvement (NRI).
results: The strongest independent predictors of CV events are shown in the table, others included were, history of stroke, atrial fibrillation, urine 
albumin creatinine ratio, diastolic BP, eGFR, smoking, heart rate, insulin use, sex and ECG variables. The C statistic was 0.717. NT-proBNP was 
elevated above the upper limit of normal in 3399(61%) and hsTnT in 3146(56%). After adding cardiac biomarkers the C statistic increased to 0.763 
and NRI was 26% (95% CI 20-30%).
conclusions: In high risk patients with T2DM, cardiac biomarkers of myocardial stress or injury enhance CV risk prediction over most traditional 
clinical variables.
Strongest predictors of CV events in patients with T2DM
Variable
HR(95%CI)prior to the 
addition of cardiac 
biomarkers
P prior to the addition 
of cardiac biomarkers
Chi square prior to the 
addition of cardiac 
biomarkers
HR(95%CI)after the 
addition of cardiac 
biomarkers
P after the 
addition of cardiac 
biomarkers
Chi square after the 
addition of cardiac 
biomarkers
History of heart 
failure 2.26(1.94-2.63) <0.001 111.1 1.79(1.60-1.83) <0.001 32.15
Serum albumin (per 
1g/L increase) 0.93(0.92-0.95) <0.001 75.5 0.98(0.96-1.00) 0.039 4.2
Age (per year 
increase) 1.03(1.02-1.04) <0.001 47.4 1.02(1.01-1.03) <0.001 15.6
History of CHD 1.49(1.30-1.72) <0.001 32.3 1.12(0.95-1.32) 0.18 1.9
LDL (per 1mmol/L 
increase) 1.17(1.10-1.24) <0.001 27.8 1.23(1.52-1.74) <0.001 34.8
HbA1c (per 1% 
increase) 1.07(1.03-1.11) <0.001 25.6 1.10(1.05-1.15) <0.001 16.9
Systolic BP (per 
10mmHg increase) 1.10(1.06-1.15) <0.001 23.9 1.07(1.01-1.12) 0.01 4.2
log NT-proBNP (per 
1 log unit increase) NA NA NA 1.62(1.52-1.74) <0.001 189.1
log hsTnT (per 1 log 
unit increase) NA NA NA 1.31(1.18-1.47) <0.001 23.6
